# Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.

> **NCT07164053** · — · NOT_YET_RECRUITING · sponsor: **Leica Microsystems (Schweiz) AG** · enrollment: 32 (estimated)

## Conditions studied

- High-Grade Glioma (WHO III-IV)
- Cerebral Vascular Conditions Requiring Surgical Intervention
- Conditions Requiring Plastic and Reconstructive Surgery

## Interventions

- **DEVICE:** MyVeo is an all-in-one surgical visualization headset used with compatible surgical microscopes and other medical imaging systems in the area of neurosurgery, ENT, spine, plastic and reconstructive su

## Key facts

- **NCT ID:** NCT07164053
- **Lead sponsor:** Leica Microsystems (Schweiz) AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-06-30
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2025-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07164053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07164053, "Evaluation of Image Quality and Safety of the MyVeo Surgical Visualization Headset During Standard Neurosurgical and Reconstructive Procedures Using Compatible Microscopes.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07164053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
